Patrick Cauntay

Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response

S. Freier, S. Henry, T. Machemer, 2012, Journal of Pharmacology and Experimental Therapeutics.

Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes.

S. Booten, S. Murray, M. Graham, 2016, Journal of medicinal chemistry.

Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts

Christopher E. Hart, S. Freier, M. Sabripour, 2015, Nucleic acids research.

Inflammatory Non-CpG Antisense Oligonucleotides Are Signaling Thought TLR9 in Human Burkitt Lymphoma B Bjab Cells.

S. Damle, S. Henry, T. Machemer, 2022, Nucleic acid therapeutics.

Mechanism Driven Early Stage Identification and Avoidance of Antisense Oligonucleotides Causing TRL9 Mediated Inflammatory Responses in Bjab cells

S. Damle, S. Henry, T. Machemer, 2021, bioRxiv.

Hybrid Mouse Diversity Panel Identifies Genetic Architecture Associated with the Acute Antisense Oligonucleotide-Mediated Inflammatory Response to a 2'-O-Methoxyethyl Antisense Oligonucleotide.

Richard G. Lee, Calvin Pan, R. Crooke, 2019, Nucleic acid therapeutics.

The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides.

Shuling Guo, S. Henry, C. Bennett, 2017, Nucleic acid therapeutics.